Clinical Research Organization

Two shareholders in a clinical research organization (CRO) retained Caliber to determine the fair market value of the company’s shares to assist in finalizing a buy/sell agreement. The CRO researches and develops clinical treatments for its external clients and internal development program.

The clients were adversarial and we were asked to provide a valuation for mediation purposes.

ConnectU v. Facebook

Dr. Sarin was engaged by counsel for Facebook, Inc. and its related parties (“Facebook”) to examine whether a settlement agreement between ConnectU, Inc. (and its related parties) indicates that Facebook and ConnectU had reached an agreement on all material terms of their settlement. We were also asked to opine on the report of ConnectU’s expert witness, Donna M. Hitscherich. Dr. Sarin opined that the Settlement Agreement unambiguously sets forth all material terms, including those with respect to the consideration for the settlement and form of the transaction.

The U.S. District Court ruled that the settlement agreement is enforceable, noting that the Agreement clearly states the consideration for the performance required and how it must be paid, and that it clearly defines the structure of the transaction.